The UK just made history, becoming the first European country to greenlight Foundayo, a new daily weight-loss pill. Because apparently, we're all looking for a little less drama at the dinner table.
This isn't just any pill; it's from Eli Lilly, the same pharmaceutical titan behind the Mounjaro jab. Foundayo is gunning for both obesity and type 2 diabetes, which, if you think about it, is a pretty ambitious two-for-one deal.
Your Stomach's New Best (Or Worst) Friend
Foundayo is a GLP-1 medication, which is science-speak for 'it tells your brain to chill out on the hunger pangs.' The Medicines and Healthcare products Regulatory Agency (MHRA) gave it the nod, but don't go clearing out your local pharmacy just yet. It's not automatically on the NHS, meaning for now, you'll need a private prescription and a wallet ready to open.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxEli Lilly isn't stopping there. They're already planning to ask the National Institute for Health and Care Excellence (NICE) to recommend Foundayo for NHS weight loss treatment. It's already an NHS player for type 2 diabetes, so it's got a foot in the door.
Dr. Simon Cork from Anglia Ruskin University noted that while Foundayo might not be the most aggressive weight-loss tool out there, patients can still expect "significant, clinically meaningful changes." And here's the kicker: it’s likely to be cheaper than other weight-loss options, which have often been pricier than a small car and just as hard to get on the NHS.
Professor Naveed Sattar from the University of Glasgow called the approval "good news," highlighting Foundayo's sheer convenience. Unlike the Wegovy pill, which demands an empty stomach and impeccable timing, Foundayo can be popped whenever. Because who needs more rules when you're just trying to eat less?
Experts are also buzzing about its potential to help people keep the weight off after they stop those GLP-1 injections. Trials showed that folks taking the tablet daily for a year didn't pile much weight back on – a common, and frankly, infuriating, problem when you stop injectables. So, less hunger, more convenience, and maybe, just maybe, an end to the weight-loss yo-yo. What could possibly go wrong? (Besides the usual nausea, diarrhea, constipation, and vomiting, of course. Always read the label. And maybe still hit the gym.)
